Andrea S. James - 28 Sep 2025 Form 4 Insider Report for Insight Molecular Diagnostics Inc. (OCX)

Role: Chief Financial Officer
Signature: /s/ Andrea James
Issuer symbol: OCX
Transactions as of: 28 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 30 Sep 2025, 16:57:45 UTC
Previous filing: 28 Mar 2025
Next filing: 13 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
James Andrea S.	Chief Financial Officer	C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE	/s/ Andrea James	30 Sep 2025	0002027010

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMDX	Option to Purchase Common Stock	Award	$0	+235,000		$0.000000	235,000	28 Sep 2025	Common Stock	235,000	$3.33	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.